• DPP-4 Inhibitors May Up Risk of Bullous Pemphigoid in Some Diabetics

    14 days ago - By Medscape

    In certain patients with type 2 diabetes, starting DPP-4 inhibitors may increase the risk of developing bullous pemphigoid, compared with therapy with second-generation sulfonylurea, according to new research.
    Reuters Health Information
    Read more ...